Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New functionally selective muscarinic agonists

G Lambrecht1, U Moser, U Grimm

  • 1Department of Pharmacology, University of Frankfurt, Germany.

Life Sciences
|January 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

To reduce cytotoxicity when testing the virucidal activity of chemical disinfectants and biocides: The "T-25 method" as an alternative to "large-volume-plating".

Heliyon·2023
Same author

Ultrastructural calcium distribution and myocardial calcium content in human idiopathic dilated cardiomyopathy.

Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology·2015
Same author

Functional assessments for decision-making regarding return to sports following ACL reconstruction. Part II: clinical application of a new test battery.

Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA·2015
Same author

[The assessment of biological maturation for talent selection - which method can be used?].

Sportverletzung Sportschaden : Organ der Gesellschaft fur Orthopadisch-Traumatologische Sportmedizin·2015
Same author

Variations of in vitro nitroglycerine permeation through human epidermis.

Pharmaceutical research·2013
Same author

Pharmacodynamics of basic triamterene derivatives.

Pharmaceutical research·2013
Same journal

Corrigendum to "Adipose stem cells-derived microvesicles and chicken egg-derived exosomes attenuate cardiac ischemia/reperfusion injury through AKT/ERK/Nrf2/HO-1 axis to inhibit apoptosis and inflammation and restore autophagy" [Life Sci. 395 (2026) 124364].

Life sciences·2026
Same journal

MAGED1 stabilizes NEUROD1 to promote Per3 expression in the pineal gland.

Life sciences·2026
Same journal

TNF-centered network pharmacology and molecular modeling of selected Andrographis paniculata compounds in hypertension.

Life sciences·2026
Same journal

Retraction notice to "Beneficial effect of Calculus Bovis Sativus on 17α-ethynylestradiol-induced cholestasis in the rat" [Life Sci. 113 (2014) 22-30].

Life sciences·2026
Same journal

Soluble PD-1 drives renal fibrosis in CKD by disrupting immune homeostasis: Therapeutic mitigation via a targeted sPD-1 sequestration strategy.

Life sciences·2026
Same journal

METTL1 promotes hepatic steatosis by mediating m<sup>7</sup>G modification of ALOX15B mRNA.

Life sciences·2026
See all related articles

Two novel muscarinic agonists, 4-F-PyMcN and 4-F-PyMcN+, show potent M1 receptor activity. These compounds may serve as valuable tools for studying muscarinic receptor mechanisms and developing M1-selective drugs.

Area of Science:

  • Pharmacology
  • Neuroscience
  • Medicinal Chemistry

Background:

  • Muscarinic receptors are crucial for various physiological processes.
  • Selective modulation of muscarinic receptor subtypes is a therapeutic goal.
  • McN-A-343 is a known muscarinic agonist, but its selectivity profile is complex.

Purpose of the Study:

  • To characterize the muscarinic pharmacology of novel McN-A-343 analogs, 4-F-PyMcN and 4-F-PyMcN+.
  • To evaluate the subtype selectivity of these novel compounds.
  • To assess their potential as research tools and therapeutic leads.

Main Methods:

  • Pharmacological assays using isolated tissues (rabbit vas deferens, rat duodenum, guinea-pig ileum and heart).
  • Radioligand binding studies to determine affinity for muscarinic receptor subtypes (M1-M4).

Related Experiment Videos

  • Calculation of potency (pEC50) and affinity (pKi, pKA) values.

    • Main Results:

    • Both 4-F-PyMcN and 4-F-PyMcN+ demonstrated potent M1 receptor agonism.
    • Compounds showed weak partial agonism or antagonism at M2 and M3 receptors.
    • 4-F-PyMcN+ exhibited limited selectivity across M1-M4 subtypes in binding assays.
    • 4-F-PyMcN showed no receptor reserve in rabbit vas deferens, with similar potency and affinity.

    Conclusions:

    • The novel compounds 4-F-PyMcN and 4-F-PyMcN+ are functionally M1-selective muscarinic agonists.
    • These agonists can serve as valuable tools for investigating muscarinic receptor function.
    • 4-F-PyMcN presents a potential starting point for developing drugs targeting central M1 receptors.